These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 30040737)

  • 21. Behavioral and psychotic symptoms of dementia (BPSD) improvements in a special care unit: a factor analysis.
    Colombo M; Vitali S; Cairati M; Vaccaro R; Andreoni G; Guaita A
    Arch Gerontol Geriatr; 2007; 44 Suppl 1():113-20. PubMed ID: 17317443
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment and management of agitation in psychiatry: Expert consensus.
    Garriga M; Pacchiarotti I; Kasper S; Zeller SL; Allen MH; Vázquez G; Baldaçara L; San L; McAllister-Williams RH; Fountoulakis KN; Courtet P; Naber D; Chan EW; Fagiolini A; Möller HJ; Grunze H; Llorca PM; Jaffe RL; Yatham LN; Hidalgo-Mazzei D; Passamar M; Messer T; Bernardo M; Vieta E
    World J Biol Psychiatry; 2016; 17(2):86-128. PubMed ID: 26912127
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Behavioral and psychological symptoms in Alzheimer's dementia and vascular dementia.
    Deardorff WJ; Grossberg GT
    Handb Clin Neurol; 2019; 165():5-32. PubMed ID: 31727229
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Psychosis and longitudinal outcomes in Huntington disease: the COHORT Study.
    Connors MH; Teixeira-Pinto A; Loy CT
    J Neurol Neurosurg Psychiatry; 2020 Jan; 91(1):15-20. PubMed ID: 31611263
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Right care, first time: a highly personalised and measurement-based care model to manage youth mental health.
    Hickie IB; Scott EM; Cross SP; Iorfino F; Davenport TA; Guastella AJ; Naismith SL; Carpenter JS; Rohleder C; Crouse JJ; Hermens DF; Koethe D; Markus Leweke F; Tickell AM; Sawrikar V; Scott J
    Med J Aust; 2019 Nov; 211 Suppl 9():S3-S46. PubMed ID: 31679171
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Systematic review and guide to management of core and psychiatric symptoms in youth with autism.
    Ameis SH; Kassee C; Corbett-Dick P; Cole L; Dadhwal S; Lai MC; Veenstra-VanderWeele J; Correll CU
    Acta Psychiatr Scand; 2018 Nov; 138(5):379-400. PubMed ID: 29904907
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Guidelines on the diagnosis, clinical assessments, treatment and management for CLN2 disease patients.
    Mole SE; Schulz A; Badoe E; Berkovic SF; de Los Reyes EC; Dulz S; Gissen P; Guelbert N; Lourenco CM; Mason HL; Mink JW; Murphy N; Nickel M; Olaya JE; Scarpa M; Scheffer IE; Simonati A; Specchio N; Von Löbbecke I; Wang RY; Williams RE
    Orphanet J Rare Dis; 2021 Apr; 16(1):185. PubMed ID: 33882967
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dementia and neuropsychiatric symptoms in nursing-home patients in Nord-Trøndelag County.
    Bergh S; Holmen J; Saltvedt I; Tambs K; Selbæk G
    Tidsskr Nor Laegeforen; 2012 Sep; 132(17):1956-9. PubMed ID: 23007358
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Scoping Review of Palliative Care for Adults with Huntington's Disease: Current Practice and Future Directions.
    El-Sourady M; Martin S; Wong HN; Carroll T
    J Palliat Med; 2022 Mar; 25(3):488-505. PubMed ID: 34847736
    [No Abstract]   [Full Text] [Related]  

  • 30. Neuropsychiatric symptoms and Apolipoprotein E: Associations with eventual Alzheimer's disease development.
    Burke SL; Maramaldi P; Cadet T; Kukull W
    Arch Gerontol Geriatr; 2016; 65():231-8. PubMed ID: 27111252
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Medical treatment of behavioral manifestations of Huntington disease.
    van Duijn E
    Handb Clin Neurol; 2017; 144():129-139. PubMed ID: 28947111
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the management of schizophrenia and related disorders.
    Galletly C; Castle D; Dark F; Humberstone V; Jablensky A; Killackey E; Kulkarni J; McGorry P; Nielssen O; Tran N
    Aust N Z J Psychiatry; 2016 May; 50(5):410-72. PubMed ID: 27106681
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An integrative review of acupressure interventions for older people: A focus on sleep quality, depression, anxiety, and agitation.
    Hmwe NTT; Browne G; Mollart L; Allanson V; Chan SW
    Int J Geriatr Psychiatry; 2019 Mar; 34(3):381-396. PubMed ID: 30430640
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Timing and Impact of Psychiatric, Cognitive, and Motor Abnormalities in Huntington Disease.
    McAllister B; Gusella JF; Landwehrmeyer GB; Lee JM; MacDonald ME; Orth M; Rosser AE; Williams NM; Holmans P; Jones L; Massey TH;
    Neurology; 2021 May; 96(19):e2395-e2406. PubMed ID: 33766994
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Classification of Neuropsychiatric Symptoms Requiring Antipsychotic Treatment in Patients with Alzheimer's Disease: Analysis of the CATIE-AD Study.
    Nagata T; Shinagawa S; Nakajima S; Plitman E; Mihashi Y; Hayashi S; Mimura M; Nakayama K
    J Alzheimers Dis; 2016; 50(3):839-45. PubMed ID: 26836181
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Psychopathology in verified Huntington's disease gene carriers.
    van Duijn E; Kingma EM; van der Mast RC
    J Neuropsychiatry Clin Neurosci; 2007; 19(4):441-8. PubMed ID: 18070848
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Distribution of agitation and related symptoms among hospitalized patients using a scalable natural language processing method.
    Hart KL; Pellegrini AM; Forester BP; Berretta S; Murphy SN; Perlis RH; McCoy TH
    Gen Hosp Psychiatry; 2021; 68():46-51. PubMed ID: 33310013
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of the psychiatric manifestations of Huntington's disease: a review of the literature.
    Leroi I; Michalon M
    Can J Psychiatry; 1998 Nov; 43(9):933-40. PubMed ID: 9825166
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Expert Consensus Guideline Series. Treatment of behavioral emergencies.
    Allen MH; Currier GW; Hughes DH; Reyes-Harde M; Docherty JP;
    Postgrad Med; 2001 May; (Spec No):1-88; quiz 89-90. PubMed ID: 11500996
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Electroconvulsive Therapy (ECT) for Refractory Psychiatric Symptoms in Huntington's Disease: A Case Series and Review of the Literature.
    Adrissi J; Nadkarni NA; Gausche E; Bega D
    J Huntingtons Dis; 2019; 8(3):291-300. PubMed ID: 31322579
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.